John-Kenneth Sake

John-Kenneth Sake has extensive work experience in the medical industry. John-Kenneth started their career as a Product Manager at Servier in 1993. John-Kenneth then moved on to UCB, where they held various roles including International Medical Advisor, Marketing Manager, and Medical Director from 1994 to 2016. Sake joined Merck Group in 2017 as the EMEA Medical Lead for Neurology & Immunology and later became the Medical Launch Lead for Europe. In 2021, they joined Merck KGaA as the Medical Lead for Neurology & Immunology in the EMEA and APAC regions. Currently, Sake is the Vice President and Head of International Medical Affairs at Blueprint Medicines, starting in 2023.

John-Kenneth Sake holds an MBA degree in MBA RUCA from the University of Antwerp, which they obtained in 1993. Prior to that, they pursued a degree in Medicine (MD) from the same university and received it in 1992. Furthermore, they completed their secondary education at Koninklijk Atheneum Antwerpen 2 from 1977 to 1984. Alongside their formal education, John-Kenneth Sake has also obtained a certification in "How to Lead and Inspire Change" from LinkedIn, the details of which are not provided.